Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study - Wikidata - awgldk - TriplyDB

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

http://www.wikidata.org/entity/Q36783294

about

Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus Acetic acid chromoendoscopy: Improving neoplasia detection in Barrett's esophagus Circulating Tumor Cells in the Adenocarcinoma of the Esophagus Update on management of Barrett's esophagus Barrett's esophagus in 2016: From pathophysiology to treatment Post-ablation surveillance in Barrett's esophagus: A review of the literature Endoscopic Therapy of Early Carcinoma of the Oesophagus Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma Spectroscopic applications in gastrointestinal endoscopy Recent developments in esophageal adenocarcinoma Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia.Human papillomavirus and gastrointestinal cancer: A review Barrett's esophagus: lessons from recent clinical trials Monitoring the premalignant potential of Barrett's oesophagus'.Screening for Barrett's Esophagus Barrett's oesophagus: frequency and prediction of dysplasia and cancer An automated approach to measuring child movement and location in the early childhood classroom.Gastric intestinal metaplasia and early gastric cancer in the west: a changing paradigm.Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus.An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling.Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm Low grade dysplasia in Barrett's esophagus: Should we worry?Comparison of cancer-associated genetic abnormalities in columnar-lined esophagus tissues with and without goblet cells.Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett's esophagus: a systematic review and meta-analysis.Body mass index, smoking, and alcohol and risks of Barrett's esophagus and esophageal adenocarcinoma: a UK prospective cohort study.Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Barrett's esophagus and cancer risk: how research advances can impact clinical practice.Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style.Barrett's oesophagus: Evidence from the current meta-analyses.Personal and family history of cancer and the risk of Barrett's esophagus in men.Feasibility, safety, acceptability, and yield of office-based, screening transnasal esophagoscopy (with video)Barrett's oesophagus: epidemiology, cancer risk and implications for management.British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort.Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.

P2860

Q24202793-E7488B5A-0BD8-49A3-BC64-CE56C3EA11EA Q26739034-761814F6-463B-45E8-A1FF-6553F2913B14 Q26741429-A58058A1-D233-455C-912C-3B93E191BA34 Q26751160-3EC1DCE1-6170-4332-9D36-F2929E25183F Q26751171-2699AA0D-738A-4A47-BFAB-6F529E5E45A6 Q26751330-70DD690E-0907-49F3-B812-22CAF4BE2A58 Q26753869-C9EE6D05-FD99-4DB2-A5B0-60047CE14A21 Q26781194-EFEAB019-0782-4F4B-AA93-25877BDFF4C6 Q26825742-BC8B11AD-0897-4D09-B8C2-C004408D9BCE Q26825773-F3B2C30D-EECD-46F0-B896-42A3A3E508C6 Q26849652-538A0E85-E6E5-4CA6-8117-E7F08F0C3E28 Q26864783-243CD483-D8BF-49E8-8A6E-CEEEE3505C92 Q27026253-26CB9167-2F0C-4FE4-8B9D-A6DC8575ABE9 Q27332349-4FD8E0A6-5E27-4C26-B1D1-1E0DA6F41BE6 Q28069930-1BB3C5A8-9A29-446B-86D0-A9DD4BD7CC57 Q28077141-F13D9472-2432-4AC0-B6CB-85CB931A6276 Q28080195-C25EBAC6-0765-48F7-9DA7-E9610E838C0C Q28080445-C2FE8CD2-2AC5-4E5B-A9C7-2783F0DA479B Q28080794-6B91F3F6-7572-48D0-B39C-F36CABCDF409 Q30402879-E30D8A36-E9F7-414C-A1D4-CA31736F3366 Q30411962-A4DB20E2-E698-419A-B4B9-8D951231A180 Q30619561-76074C20-C1B9-444E-AEC7-F1613E90D928 Q30685917-448D34E7-59CE-4512-B7A8-399631758CA1 Q30942653-6B028471-1613-46E1-B485-34ECA9F8C54A Q31050730-86DD918B-06BC-4498-A434-6C6841943CEB Q33628118-F8E55B05-449D-4900-B13A-C69AA9E872C5 Q33717444-BC8E3A58-0EB8-4005-9FD7-363DA409E11E Q33746567-9521D76A-B98A-4B01-B674-6BD60262D91A Q33794461-1848929F-E06E-4874-AAD5-EF6DC386D50D Q33948451-40C3A5CC-761E-4AC7-B1F0-E479D719A9FB Q33959620-81885A14-1096-4E10-96E0-CD71ED484C84 Q33975855-378E04AC-FA97-4741-871A-084F875CCCEF Q34046479-6C73BB27-F79B-4D14-B2D9-EBDB5A70B328 Q34047978-FD67BDE9-500D-400F-AAA3-77FAA3E1F6A7 Q34054028-B3BB7CD4-60A2-45F4-9EDF-568A36AC4309 Q34132822-C6253966-8978-4B56-8DA8-FD3F1243F528 Q34375216-1EEFC0AD-B19F-45CC-A473-BA22A97EA15C Q34380645-A205B6B3-84C0-467D-A985-09F958DB2AA9 Q34457732-314B75C4-E9E7-4531-A0DE-D4D13B77650F Q34471340-779B4C53-DC15-4848-B40C-288CD23D5F57

P2860

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study

http://www.wikidata.org/entity/Q36783294

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Risk of malignant progression ...... a large population-based study

@en

type

label

Risk of malignant progression ...... a large population-based study

@en

prefLabel

Risk of malignant progression ...... a large population-based study

@en

P1433

Q36783294-D7990FDA-D982-489D-8A0C-F5A1527E5B4E

P1476

Q36783294-B78C8149-C66A-478D-94AA-9EA8F3823AA3

P2093

Q36783294-01A100AA-BEA0-47C9-801B-B0618B5B41BD

Q36783294-098025CE-AB36-48ED-BBCB-B8E18730E26F

Q36783294-5DBA53AA-1844-40EF-A826-A26E1D1B8896

Q36783294-7560152C-5CA7-42D6-ACAD-07BFDD8105D1

Q36783294-7EA82C83-F826-47BC-8FC5-F8421EB997F5

Q36783294-A80E406D-7CE0-4B45-8064-A3DAC2D50793

Q36783294-F8934E1D-58B0-4588-9BF9-0370370217C6

P2860

Q36783294-04072903-3502-4096-93F6-85BF4E7DD155

Q36783294-0DB2A3B6-3FB1-4D36-81B1-47F1EC0BF9F1

Q36783294-127DFFA0-861F-475D-BFA7-8FC28A62AE3F

Q36783294-1C6DE7C4-FEB6-432A-ABBB-7A8826B4303D

Q36783294-207DE2B6-112A-4105-B881-F8FDC6484B2A

Q36783294-2C8B1BB5-E307-48E5-A7BB-7AEA971B79D0

Q36783294-2E600E37-2DAF-41AB-AB6D-A026B2E2CDB3

Q36783294-3096D0CE-2C28-49FA-8060-BF5CB462F0EB

Q36783294-32A0C196-E67D-4521-92E1-7658789BA4FF

Q36783294-423D001E-933C-4079-A244-C4AD3208506C

P304

Q36783294-C8BEB329-E77F-4456-AC17-93986C6B3426

P31

Q36783294-D09587C6-1AAC-4E87-8479-816C4C5D0072

P356

Q36783294-22D78D79-1D5D-4177-9369-68BF1DA20466

P407

Q36783294-04790A8E-E664-4AE1-A665-0EAFC0FAC026

P433

Q36783294-97585565-C5BC-47E0-B24B-C3197D16A1C6

P478

Q36783294-98EDF794-D9C6-4F15-8CBE-936AB468DED6

P577

Q36783294-A2C51F51-F434-4925-AF5D-DF22F25C83CA

P5875

Q36783294-13F1F461-0FDD-4009-97A3-B96B9CFBAE1C

P698

Q36783294-A08E1F27-ED22-439A-A964-BA19820C46F2

P932

Q36783294-538F55F3-CFCE-497A-A02D-704DDEE91221

P356

P1433

Journal of the National Cancer Institute

P1476

Risk of malignant progression ...... a large population-based study

@en

P2093

Anna T Gavin

http://www.w3.org/2001/XMLSchema#string

Brian T Johnston

http://www.w3.org/2001/XMLSchema#string

Damian T McManus

http://www.w3.org/2001/XMLSchema#string

Fouad Yousef

http://www.w3.org/2001/XMLSchema#string

Helen G Coleman

http://www.w3.org/2001/XMLSchema#string

Liam J Murray

http://www.w3.org/2001/XMLSchema#string

Shivaram Bhat

http://www.w3.org/2001/XMLSchema#string

P2860

Barrett's oesophagus: results from a 13-year surveillance programme.

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study.

The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett.

Cost effectiveness of detecting Barrett's cancer.

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis.

Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.

Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia.

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.

P304

1049-1057

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJR203

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51226489

http://www.w3.org/2001/XMLSchema#string

P698

21680910

http://www.w3.org/2001/XMLSchema#string

P932

3632011

http://www.w3.org/2001/XMLSchema#string